Protara Therapeutics Stock Overlap Studies Triple Exponential Moving Average

TARA Stock  USD 2.39  0.10  4.37%   
Protara Therapeutics overlap studies tool provides the execution environment for running the Triple Exponential Moving Average study and other technical functions against Protara Therapeutics. Protara Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Triple Exponential Moving Average study function is designed to identify and follow existing trends. Protara Therapeutics overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was six with a total number of output elements of fifty-five. Protara Therapeutics Triple Exponential Moving Average indicator shows smoothing effect of Protara Therapeutics price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.

Protara Therapeutics Technical Analysis Modules

Most technical analysis of Protara Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Protara from various momentum indicators to cycle indicators. When you analyze Protara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Protara Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Protara Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Protara Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Protara Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Protara Therapeutics's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Protara Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Protara Therapeutics, we also check how macroeconomic factors affect Protara Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2020 2021 2022 2023 (projected)
PB Ratio0.880.470.30.31
Capex To Depreciation4.515.090.480.13
Hype
Prediction
LowEstimatedHigh
0.122.416.32
Details
Intrinsic
Valuation
LowRealHigh
2.159.6013.51
Details
Naive
Forecast
LowNextHigh
0.042.025.93
Details
4 Analysts
Consensus
LowTargetHigh
28.5731.4034.85
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run AI Portfolio Architect Now

   

AI Portfolio Architect

Use AI to generate optimal portfolios and find profitable investment opportunities
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 60 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
Momentum Idea
Momentum
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
When determining whether Protara Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Protara Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Protara Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Protara Therapeutics Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Protara Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Protara Stock refer to our How to Trade Protara Stock guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protara Therapeutics. If investors know Protara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protara Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.64)
Return On Assets
(0.28)
Return On Equity
(0.46)
The market value of Protara Therapeutics is measured differently than its book value, which is the value of Protara that is recorded on the company's balance sheet. Investors also form their own opinion of Protara Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protara Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protara Therapeutics' market value can be influenced by many factors that don't directly affect Protara Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protara Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protara Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protara Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.